Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. (Q52113945)

22 April 2018

title

Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. (English)

1 reference

22 April 2018

main subject

schizophrenia

0 references

author

Katja Cattapan-Ludewig

4

object named as

Katja Ludewig

1 reference

22 April 2018

author name string

Lorenz Leumann

1

1 reference

22 April 2018

Joram Feldon

2

1 reference

22 April 2018

Franz X Vollenweider

3

1 reference

22 April 2018

language of work or name

English

0 references

publication date

1 October 2002

1 reference

22 April 2018

published in

Biological Psychiatry

1 reference

22 April 2018

volume

52

1 reference

22 April 2018

page(s)

729-739

1 reference

22 April 2018

issue

7

1 reference

22 April 2018

Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Effects of tobacco smoking, schizotypy and number of pre-exposures on latent inhibition in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Prestimulus effects on human startle reflex in normals and schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Sensorimotor gating and schizophrenia. Human and animal model studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Gating and habituation of the startle reflex in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Neuroanatomy of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Left temporal lobe dysfunction in schizophrenia: event-related potential and behavioral evidence from phonetic and tonal dichotic listening tasks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Transient versus sustained visual channels in the visual backward masking deficits of schizophrenia patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Latent inhibition in smokers vs. nonsmokers: interaction with number or intensity of preexposures?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The effects of smoking on acoustic prepulse inhibition in healthy men and women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Effects of smoking on acoustic startle and prepulse inhibition in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Continuous performance test and schizophrenia: a test of stimulus-response compatibility, working memory, response readiness, or none of the above?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Effects of nicotine and stress on startle amplitude and sensory gating depend on rat strain and sex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Nicotine administration impairs sensory gating in Long-Evans rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The psychological significance of human startle eyeblink modification: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Elementary neuronal dysfunctions in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Startle gating deficits occur across prepulse intensities in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The positive and negative syndrome scale (PANSS) for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Acoustic startle, prepulse inhibition, locomotion, and latent inhibition in the neuroleptic-responsive (NR) and neuroleptic-nonresponsive (NNR) lines of mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The neurobiology of startle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Prepulse Inhibition of the Startle Response in Men With Schizophrenia: Effects of Age of Onset of Illness, Symptoms, and Medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Pyrimidine morpholino oligonucleotides form a stable triple helix in the absence of magnesium ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Blockade of latent inhibition following pharmacological increase or decrease of GABA(A) transmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Latent inhibition as a measure of learned inattention: some problems and solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Latent inhibition in humans: data, theory, and implications for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

"Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Disorders of attention and perception in early schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The pharmacology of latent inhibition as an animal model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Information processing and attentional functioning in the developmental course of schizophrenic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The P50 auditory event-evoked potential in adult attention-deficit disorder: comparison with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Information-processing deficits and thought disorder in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The schizophrenia spectrum: a study of the relationship among the Rorschach, MMPI, and visual backward masking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Lesions of the nucleus basalis magnocellularis do not impair prepulse inhibition and latent inhibition of fear-potentiated startle in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The latent inhibition model dissociates between clozapine, haloperidol, and ritanserin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Relations between attentional deficits and clinical symptoms in schizophrenic outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Latent inhibition in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Facilitation of latent inhibition by haloperidol in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The latent inhibition model of schizophrenic attention disorder and of antipsychotic drug action: comment on Dunn, Atwater and Kilts (Psychopharmacology, 1993, 112:315-323)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The switching model of latent inhibition: an update of neural substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Dissociation between the effects of pre-weaning and/or post-weaning social isolation on prepulse inhibition and latent inhibition in adult Sprague--Dawley rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Dichotic listening in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

Attention deficits assessed by Continuous Performance Test and Span of Apprehension Test in Japanese schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Schizophrenic deficit in span of apprehension

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901344-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(02)01344-6

1 reference

22 April 2018

PubMed ID

12372664

1 reference

22 April 2018